Organometallics
Article
1
product was obtained. H NMR (CDCl3 at 25 °C; δ): 7.59 (apparent
t, J = 7.5 Hz, 1H), 7.49 (t, J = 8.4 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H),
7.39 (t, J = 7.3 Hz, 1H), 6.76 (dd, J = 7.5 and 2.2 Hz, 1H), 6.48 (d, J =
8.5 Hz, 2H), 4.54 (septet, J = 6.0 Hz, 2H), 2.22−2.15 (multiple peaks,
4H), 1.85−1.76 (multiple peaks, 6H), 1.72−1.66 (br, 2H), 1.62−1.53
(br, 2H), 1.40−1.31 (br, 2H), 1.36 (d, J = 6.0 Hz, 6H), 1.25 (m, 2H),
1.22−1.12 (multiple peaks, 4H), 1.00 (d, J = 6.0 Hz, 6H). 13C{1H}
1.69 (br, 2H), 1.61 (m, 2H), 1.38−1.22 (multiple peaks, 6H), 1.34 (d,
J = 5.8 Hz, 6H), 1.18 (m, 2H), 1.00 (d, J = 6.2 Hz, 6H). 13C{1H}
NMR (CDCl3 at 25 °C; δ): 163.45, 161.63 (t, J = 22.5 Hz), 144.78 (d,
J = 16.4 Hz), 139.14, 133.86 (d, J = 44.3 Hz), 131.90 (d, J = 11.6 Hz),
131.41 (d, J = 1.4 Hz), 131.30, 126.54 (d, J = 6.1 Hz), 121.53−115.68
(three overlapping multiplets CF2, CF3 and CF3), 106.69 (tqd, 1JC−F
=
2
3
263.0 Hz, JC−F = 37.5 Hz, JC−P = 6.8 Hz), 105.61, 103.01, 71.60,
36.14 (d, J = 26.6 Hz), 29.32, 28.92 (d, J = 3.4 Hz), 27.22−26.96 (two
overlapping d), 25.96, 21.73, 21.48. 19F NMR (CDCl3 at 25 °C; δ):
−76.10 (d, J = 34.8 Hz, 2F), −78.98 (s, 2F), −82.58 (s, 3F), −119.10
(s, 3F). 31P{1H} NMR (CDCl3 at 25 °C; δ): 49.11 (t, J = 33.9 Hz).
19F/13C HSQC NMR (CDCl3 at 25 °C; δF/δC): −76.10/118.35,
−78.98/118.46, −82.58/118.75, −119.10/106.64. 19F/13C HMBC
NMR (CDCl3 at 25 °C; δF/δC): −76.10/118.35 (1J correlation),
−76.10/118.46, −78.98/118.35, −78.98/118.46 (1J correlation),
−82.58/106.64, −82.58/118.75 (1J correlation), −119.10/106.64 (1J
correlation), −119.10/118.75, −119.10/161.61. IR (ATR; cm−1):
2987 (w), 2938 (m), 2922 (m), 2859 (m), 1692 (s), 1588 (s), 1570
(m), 1447 (s), 1386 (s), 1333 (s), 1287 (m), 1255 (s), 1206 (s), 1161
(s), 1108 (s), 1061 (s), 1026 (s). HRMS electrospray (m/z): [M −
OCOC2F5]+ calcd for C32H43F5O2PPd 691.1950, found 691.1962.
Preparation of [(RuPhos)2Pd2](CF3COO)2 (8). A solution of
(RuPhos)Pd(COCF3)(OCOCF3) (1; 200 mg; 0.26 mmol) in benzene
(7 mL) was allowed to stand for 24 h at room temperature. During
this time the solution changed from yellow to deep red, and bright red
crystals slowly crystallized from solution. The benzene supernatant was
removed by decanting, and two 2 mL portions of benzene were used
to wash the crystals. After drying under vacuum, 78 mg (44%) of a
2
3
NMR (CDCl3 at 25 °C; δ): 207.98 (td, JC−F = 40.2 Hz, JC−P = 7.0
Hz), 161.37 (t, JC−F = 25.9 Hz), 161.04, 144.68 (d, J = 17.0 Hz),
137.38, 133.07 (d, J = 43.6 Hz), 131.78 (d, J = 11.6 Hz), 131.47 (d, J =
1.7 Hz), 130.94, 126.71 (d, J = 6.1 Hz), 121.44−114.17 (two
overlapping multiplets, 2 × CF2), 106.64 (m, CF3), 105.98, 105.29,
2
1
2
3
101.53 (tqd, JC−F = 269.8 Hz, JC−F = 36.1 Hz, JC−P = 14.3 Hz),
71.19, 34.28 (d, J = 29.3 Hz), 28.26 (two overlapping signals), 26.75
(two overlapping d), 25.85, 21.74, 21.67. 19F NMR (CDCl3 at 25 °C;
δ): −80.18 (s, 3F), −82.40 (s, 3F), −-112.23 (s, 2F), −118.44 (broad
s, 2F). 31P{1H} NMR (CDCl3 at 25 °C; δ): 42.25 (s). 19F/13C HSQC
NMR (CDCl3 at 25 °C; δF/δC): −80.18/117.33, −82.40/118.70,
−112.23/101.53, −118.44/106.64. 19F/13C HMBC NMR (CDCl3 at
25 °C; δF/δC): −80.18/101.53, −80.18/117.33 (1J correlation),
−112.23/101.53 (1J correlation), −112.23/117.33, −112.23/207.98.
IR (ATR): cm−1 2978 (w), 2987 (w), 2937 (m), 2855 (w), 1716 (s),
1684 (s), 1588 (m), 1569 (m), 1451 (s), 1384 (m), 1327 (s), 1256
(s), 1202 (s), 1162 (s), 1110 (s), 1069 (s). HRMS electrospray (m/z):
[M − OCOC2F5]+ calcd for C33H43F5O3PPd 719.1899, found
719.1916; [M − OCOC2F5 − CO]+ calcd for C32H43F5O2PPd
691.1950, found 691.1969.
Preparation of (RuPhos)Pd(CF3)(OCOCF3) (6). (RuPhos)Pd-
(COCF3)(OCOCF3) (1) (300 mg; 0.38 mmol) was refluxed in
benzene (25 mL) for 1.5 h. 19F and 31P NMR analysis of the crude
reaction mixture showed complete conversion to product 6. The
benzene solution was filtered through a pad of Celite, and the volatiles
were removed under reduced pressure. The residue was dissolved in
diisopropyl ether (5 mL). The product slowly crystallized over a
period of 12 h. Yellowish crystals were collected by filtration, washed
with a small amount of diisopropyl ether, and dried under vacuum. A
1
bright orange powder was obtained. H NMR (acetone-d6 at 25 °C;
δ): 8.61 (m, 1H), 8.12 (m, 1H), 7.80 (t, J = 7.3 Hz, 1H), 7.75 (t, J =
7.7 Hz, 1H), 7.41 (d, J = 7.7 Hz, 1H), 5.60 (d, J = 7.0 Hz, 2H), 4.39
(septet, J = 6.1 Hz), 3.26 (m, 2H), 2.19−2.09 (multiple peaks, 4H),
1.83 (m, 4H), 1.74 (m, 2H), 1.59 (m, 2H), 1.51 (m, 2H), 1.46−1.35
(multiple peaks, 4H), 1.23 (m, 2H), 0.95 (d, J = 6.1 Hz, 6H), 0.81 (d, J
= 6.0 Hz, 6H). 13C{1H} NMR (acetone-d6 at 25 °C; δ): 159.03 (q, J =
36.7 Hz), 151.39, 144.54 (virtual t, J = 27.2 Hz), 138.27 (virtual t, J =
42.2 Hz), 133.31, 132.90, 131.41 (virtual t, JC−P = 16.4 Hz), 129.37
(virtual t, JC−P = 6.2 Hz), 116.42 (q, J = 290.9 Hz), 94.08, 86.69, 80.45,
73.30, 36.18 (virtual t, J = 20.6 Hz), 29.83, 29.32, 26.17−26.00 (two
overlapping t), 25.74, 20.58, 19.95. 19F NMR (acetone-d6 at 25 °C; δ):
−76.38 (s). 31P{1H} NMR (acetone-d6 at 25 °C; δ): 61.46 (s).
19F/13C HSQC NMR (acetone-d6 at 25 °C; δF/δC): −76.38/116.45.
19F/13C HMBC NMR (acetone-d6 at 25 °C; δF/δC): −76.38/116.45
(1J correlation), −76.38/159.03. HRMS electrospray (m/z): [M −
OCOCF3]+ calcd for C62H86F3O6P2Pd 1257.3905, found 1257.3921,
[M − 2OCOCF3]2+ calcd for C30H43O2PPd 572.2030, found
572.2049.
1
227 mg amount (78%) of product was obtained. H NMR (CDCl3 at
25 °C; δ): 7.63 (apparent triplet, J = 7.3 Hz, 1H), 7.54 (t, J = 8.5 Hz),
7.43 (t, J = 7.3 Hz), 7.38 (t, J = 7.3 Hz), 6.68 (broad d, J = 6.2 Hz),
6.50 (d, J = 8.5 Hz), 4.60 (septet, J = 6.2 Hz), 2.26 (m, 2H), 2.16 (br,
2H), 1.90 (br, 2H), 1.80 (multiple peaks, 4H), 1.68 (br, 2H), 1.58 (m,
2H), 1.41−1.11 (multiple peaks, 8H), 1.30 (d, J = 5.8 Hz, 6H), 0.99
(d, J = 6.2 Hz, 6H). 13C{1H} NMR (CDCl3 at 25 °C; δ): 163.49,
161.25 (q, J = 34.1 Hz), 144.85 (d, J = 16.3 Hz), 138.82, 134.17 (d, J =
44.3 Hz), 131.75 (d, J = 12.3 Hz), 131.54 (d, J = 1.5 Hz), 131.40,
126.58 (d, J = 6.1 Hz), 118.59 (qd, 1JC−F = 379.4 Hz, 3JC−P = 15.0 Hz),
116.39 (q, 1JC−F = 290.9 Hz), 105.73, 102.92, 71.60, 35.93 (d, J = 27.9
Hz), 29.28, 29.01, 27.00 (two overlapping d), 25.93, 21.96, 21.30. 19F
NMR (CDCl3 at 25 °C; δ): −10.38 (d, J = 29.8 Hz, 3F), −74.90 (s,
3F). 31P{1H} NMR (CDCl3 at 25 °C; δ): 51.35 (q, J = 29.7 Hz).
19F/13C HSQC NMR (CDCl3 at 25 °C; δF/δC): −10.38/118.59,
−74.90/116.39. 19F/13C HMBC NMR (CDCl3 at 25 °C; δF/δC):
−74.90/161.33. IR (ATR; cm−1): 2978 (w), 2931 (m), 2856 (m),
1698 (s), 1589 (m), 1445 (s), 1405 (m), 1378 (m), 1258 (s), 1193
(s), 1173 (s), 1130 (s), 1108 (s), 1068 (s). HRMS electrospray (m/z):
[M − OCOCF3]+ calcd for C31H43F3O2PPd 641.1982, found
641.1994.
Preparation of (RuPhos)Pd(C2F5)(OCOC2F5) (7). (RuPhos)Pd-
(COC2F5)(OCOC2F5) (5; 220 mg; 0.25 mmol) was refluxed in
benzene (50 mL) for 1.5 h. 19F and 31P NMR analysis of the crude
reaction mixture showed complete conversion to product 7. This
benzene solution was filtered through a pad of Celite, and the volatiles
were removed under reduced pressure. The residue was dissolved in
diethyl ether (5 mL). The product slowly crystallized over a period of
several hours. Yellowish crystals were collected by filtration, washed
with a small amount of ether, and dried under vacuum to afford 133
mg (62%) of product 7. 1H NMR (CDCl3 at 25 °C; δ): 7.63 (apparent
t, J = 7.3 Hz, 1H), 7.54 (t, J = 7.5 Hz), 7.42 (t, J = 7.7 Hz), 7.37 (t, J =
7.7 Hz), 6.69 (broad d, J = 7.3 Hz), 6.46 (d, J = 8.5 Hz), 4.55 (septet, J
= 6.2 Hz), 2.29 (m, 2H), 2.22 (br, 2H), 1.91 (br, 2H), 1.81 (br, 4H),
Preparation of (RuPhos)Pd(CF3)(Ph) (9). A Schlenk flask was
charged with a stirbar, diphenylzinc (200 mg; 0.91 mmol), and
(RuPhos)Pd(CF3)(OCOCF3) (6; 450 mg; 0.60 mmol). The flask was
sealed, evacuated under reduced pressure, and then refilled with
nitrogen. The flask was evacuated and refilled with nitrogen three
more times. Dry THF (20 mL) was added via cannula. The resulting
solution was stirred at room temperature for 20 min, and then water
(0.2 mL) was introduced. The reaction mixture was stirred at room
temperature for an additional 20 min. Then the THF solution was
dried over anhydrous Na2SO4 and filtered. The volatiles were removed
under reduced pressure. The resulting residue was dissolved in
diisopropyl ether, and the product was allowed to crystallize from
solution over a period of several hours. Colorless crystals were
collected by filtration, washed with a small amount of diisopropyl
ether, and dried under vacuum. A 180 mg amount (42%) of 9 was
obtained. 1H NMR (CDCl3 at 25 °C; δ): 7.53 (apparent t, J = 6.9 Hz,
1H), 7.42−7.32 (multiple peaks, 3H), 7.23 (d, J = 7.4 Hz, 2H), 7.18
(broad d, J = 4.7 Hz, 1H), 7.02 (d, J = 8.3 Hz, 1H), 6.88 (t, J = 7.4 Hz,
2H), 6.82 (t, J = 7.1 Hz, 1H), 4.52 (septet, J = 6.0 Hz, 2H), 1.88−1.78
(br, 2H), 1.76−1.44 (multiple peaks, 12H), 1.32−1.02 (multiple
peaks, 8H), 1.28 (d, J = 6.0 Hz, 6H), 0.99 (d, J = 6.0 Hz, 6H). 13C{1H}
NMR (CDCl3 at 25 °C; δ): 154.11, 145.09 (br), 141.31 (d, J = 13.6
Hz), 140.84 (m, CF3), 136.54 (d, J = 2.0 Hz), 134.73 (d, J = 6.8 Hz),
2657
dx.doi.org/10.1021/om500398z | Organometallics 2014, 33, 2653−2660